Impact of Deucravacitinib on Plaque Psoriasis Treatment Landscape
March 20th 2024An expert in dermatologic conditions examines laboratory requirements for initiating deucravacitinib in patients with moderate-to-severe plaque psoriasis and the impact of deucravacitinib on the treatment landscape.
Read More